81 related articles for article (PubMed ID: 10974941)
1. [Quality of life in schizophrenic patients treated with classic and "old" atypical neuroleptics].
Jarema M; Konieczyńska Z
Psychiatr Pol; 2000; 34(2):275-88. PubMed ID: 10974941
[TBL] [Abstract][Full Text] [Related]
2. [Quality of life of patient with schizophrenia treated by conventional and atypical neuroleptics].
Zaghdoudi L; Homri W; Belaid S; Ben Bechir M; Labbane R
Tunis Med; 2009 Sep; 87(9):593-8. PubMed ID: 20180380
[TBL] [Abstract][Full Text] [Related]
3. A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables.
Naber D
Int Clin Psychopharmacol; 1995 Sep; 10 Suppl 3():133-8. PubMed ID: 8866775
[TBL] [Abstract][Full Text] [Related]
4. Improvement of patient compliance after switching from conventional neuroleptics to the atypical neuroleptic amisulpride.
Linden M; Scheel T; Eich FX
J Psychopharmacol; 2006 Nov; 20(6):815-23. PubMed ID: 16401647
[TBL] [Abstract][Full Text] [Related]
5. Subjective well-being and quality of life under atypical antipsychotic treatment.
Karow A; Naber D
Psychopharmacology (Berl); 2002 Jun; 162(1):3-10. PubMed ID: 12107610
[TBL] [Abstract][Full Text] [Related]
6. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.
Wehmeier PM; Kluge M; Schneider E; Schacht A; Wagner T; Schreiber W
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):703-12. PubMed ID: 17289237
[TBL] [Abstract][Full Text] [Related]
7. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of health-related quality of life in hospitalized schizophrenics].
Konieczyńska Z; Jarema M; Cikowska G
Psychiatr Pol; 1997; 31(3):323-31. PubMed ID: 9527677
[TBL] [Abstract][Full Text] [Related]
9. [The change of quality of life and clinical picture in schizophrenia].
Jarema M; Konieczyńska Z; Murawiec S; Szafrański T; Szaniawska A
Psychiatr Pol; 2002; 36(3):393-402. PubMed ID: 12149915
[TBL] [Abstract][Full Text] [Related]
10. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY
J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
[TBL] [Abstract][Full Text] [Related]
11. [Adverse effects of antipsychotics and quality of life].
Mínguez Martín L; González Pablos E; Alonso del Teso F; Sanguino Andrés RM; García Alonso Y
Actas Esp Psiquiatr; 2005; 33(1):1-6. PubMed ID: 15704024
[TBL] [Abstract][Full Text] [Related]
12. The effectiveness of ziprasidone in treating impaired quality of life in schizophrenia: a 12-month, open-label, flexible-dose, naturalistic observational study of patients undergoing usual care.
Ritsner MS; Yorkov V; Ratner Y; Soifer P; Gibel A
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1470-7. PubMed ID: 17669573
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
Jones PB; Barnes TR; Davies L; Dunn G; Lloyd H; Hayhurst KP; Murray RM; Markwick A; Lewis SW
Arch Gen Psychiatry; 2006 Oct; 63(10):1079-87. PubMed ID: 17015810
[TBL] [Abstract][Full Text] [Related]
14. Differences of satisfaction with medication between patients with schizophrenia treated with typical antipsychotics and atypical antipsychotics.
Watanabe A; Shibata I; Kato T
Psychiatry Clin Neurosci; 2004 Jun; 58(3):268-73. PubMed ID: 15149292
[TBL] [Abstract][Full Text] [Related]
15. [Correlation between subjective well-being and pharmacological therapy in patients with psychotic disorders].
Antonini V; Corradi A; Buizza C; Vittorielli M; Pioli R; Rossi G
Recenti Prog Med; 2004 Dec; 95(12):581-4. PubMed ID: 15666490
[TBL] [Abstract][Full Text] [Related]
16. Quality of life in schizophrenia: Impact of psychopathology, patients' gender and antipsychotic treatment.
Konieczyńska MJ
Int J Psychiatry Clin Pract; 2001; 5(1):19-26. PubMed ID: 24936992
[TBL] [Abstract][Full Text] [Related]
17. Quality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remission.
Yen CF; Cheng CP; Huang CF; Yen JY; Ko CH; Chen CS
Bipolar Disord; 2008 Jul; 10(5):617-24. PubMed ID: 18657246
[TBL] [Abstract][Full Text] [Related]
18. [The evaluation of subjective quality of life in patients with schizophrenia or depression].
Jarema M; Konieczyńska Z; Główczak M; Szaniawska A; Meder J; Jakubiak A
Psychiatr Pol; 1995; 29(5):641-53. PubMed ID: 8577905
[TBL] [Abstract][Full Text] [Related]
19. Subjective well-being and initial dysphoric reaction under antipsychotic drugs - concepts, measurement and clinical relevance.
Lambert M; Schimmelmann BG; Karow A; Naber D
Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S181-90. PubMed ID: 14677077
[TBL] [Abstract][Full Text] [Related]
20. Patients in the early phases of schizophrenia and schizoaffective disorders effectively treated with risperidone long-acting injectable.
Parellada E; Andrezina R; Milanova V; Glue P; Masiak M; Turner MS; Medori R; Gaebel W
J Psychopharmacol; 2005 Sep; 19(5 Suppl):5-14. PubMed ID: 16144781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
